Rabbit Polyclonal SMAD4 antibody. Suitable for IP, WB, IHC-P and reacts with Human, Mouse samples. Cited in 8 publications. Immunogen corresponding to Recombinant Fragment Protein within Human SMAD4 aa 1-200.
View Alternative Names
DPC4, MADH4, SMAD4, SMAD family member 4, SMAD 4, hSMAD4, Deletion target in pancreatic carcinoma 4, Mothers against decapentaplegic homolog 4, MAD homolog 4, Mothers against DPP homolog 4
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Smad4 antibody (AB236321)
Paraffin-embedded human kidney tissue stained for Smad4 using ab236321 at 1/100 dilution in immunohistochemical analysis.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Smad4 antibody (AB236321)
Paraffin-embedded human colon cancer tissue stained for Smad4 using ab236321 at 1/100 dilution in immunohistochemical analysis.
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Smad4 influences cell proliferation differentiation and apoptosis by mediating signals from TGF-beta cytokines. It is part of the Smad protein family acting as a transcriptional controller. Upon TGF-beta receptor activation Smad4 forms complexes with Smad2 and Smad3 translocating to the nucleus to regulate genes imperative for cellular homeostasis. Its role in cell cycle regulation underlines its contribution to normal cellular functions and its potential involvement in disorders.
Pathways
Smad4 operates within the TGF-beta pathway linking extracellular signals to nuclear transcription alterations. It participates in the regulation of epithelial-mesenchymal transition (EMT) a process important for development and tumor progression. In these pathways Smad4 interacts closely with Smad2 and Smad3 orchestrating various cellular responses to external stimuli through transcriptional management.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Cancer reports (Hoboken, N.J.) :e1976 PubMed38230565
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 15:151-164 PubMed36777827
2023
Applications
Unspecified application
Species
Unspecified reactive species
Current issues in molecular biology 44:5048-5066 PubMed36286058
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 13:659-671 PubMed33594316
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 18:2860-2875 PubMed31599708
2019
Applications
Unspecified application
Species
Unspecified reactive species
Medicina (Kaunas, Lithuania) 55: PubMed31238579
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 234:20275-20285 PubMed30953355
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncogenesis 8:1 PubMed30631034
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com